What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Heart failure
- Cardiology
Sanjiv J. Shah mainly focuses on Internal medicine, Cardiology, Heart failure, Heart failure with preserved ejection fraction and Ejection fraction.
His research on Internal medicine frequently links to adjacent areas such as Surgery.
His Cardiology study combines topics from a wide range of disciplines, such as Clinical endpoint, Proportional hazards model and Blood pressure.
His Heart failure research is multidisciplinary, relying on both Tolerability and Diastole.
His study in Heart failure with preserved ejection fraction is interdisciplinary in nature, drawing from both Brain natriuretic peptide, Doppler echocardiography, Diastolic heart failure, Intensive care medicine and Comorbidity.
His Ejection fraction research is multidisciplinary, incorporating elements of Interquartile range, Left ventricular hypertrophy, Myocardial infarction, Natriuretic peptide and Pulmonary wedge pressure.
His most cited work include:
- Spironolactone for Heart Failure with Preserved Ejection Fraction (1188 citations)
- Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy (589 citations)
- Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial (467 citations)
What are the main themes of his work throughout his whole career to date?
Sanjiv J. Shah mainly investigates Internal medicine, Cardiology, Heart failure, Heart failure with preserved ejection fraction and Ejection fraction.
His Pulmonary hypertension, Blood pressure, Stroke volume and Hazard ratio study in the realm of Internal medicine connects with subjects such as In patient.
His research integrates issues of Proportional hazards model and Diastole in his study of Cardiology.
His research in Heart failure intersects with topics in Clinical trial, Epidemiology and Intensive care medicine.
Sanjiv J. Shah has researched Heart failure with preserved ejection fraction in several fields, including Natriuretic peptide, Randomized controlled trial and Diastolic heart failure.
His Ejection fraction study combines topics in areas such as Body mass index and Pulmonary wedge pressure.
He most often published in these fields:
- Internal medicine (74.02%)
- Cardiology (64.63%)
- Heart failure (47.10%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (74.02%)
- Cardiology (64.63%)
- Heart failure (47.10%)
In recent papers he was focusing on the following fields of study:
Sanjiv J. Shah focuses on Internal medicine, Cardiology, Heart failure, Heart failure with preserved ejection fraction and Ejection fraction.
With his scientific publications, his incorporates both Internal medicine and In patient.
The various areas that he examines in his Cardiology study include Diabetes mellitus and Blood pressure, Diastole.
He interconnects Subclinical infection, Risk factor, Cohort and Hazard ratio in the investigation of issues within Heart failure.
His Heart failure with preserved ejection fraction research integrates issues from Clinical trial, Sacubitril, Valsartan, Coronary flow reserve, Myocardial infarction and Exercise capacity.
His Ejection fraction research includes themes of Odds ratio, Valsartan, Randomized controlled trial and Quality of life.
Between 2019 and 2021, his most popular works were:
- Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF. (72 citations)
- ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization (41 citations)
- Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy (39 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Heart failure
- Cancer
The scientist’s investigation covers issues in Heart failure, Internal medicine, Cardiology, Heart failure with preserved ejection fraction and Ejection fraction.
His work on Cardiac amyloidosis as part of general Heart failure research is frequently linked to In patient, thereby connecting diverse disciplines of science.
Sanjiv J. Shah has included themes like Body mass index, Biomarker and Blood pressure, Diastole in his Cardiology study.
His Heart failure with preserved ejection fraction research incorporates themes from Clinical trial, Randomized controlled trial, Endothelial activation, Fibrosis and Left atrial.
His biological study spans a wide range of topics, including Anesthesia, Decompensation, Stroke volume and Adverse effect.
His Ejection fraction research is multidisciplinary, incorporating perspectives in Quality of life, Ventricular remodeling, Valsartan, Subclinical infection and Hemodynamics.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
